Improved profile of bad phosphorylation and caspase 3 activation after blood versus crystalloid cardioplegia

Annals of Thoracic Surgery

Volumn 77, Issue 4, 2004, Pages 1384-1389

  Feng, Jun ^a   Bianchi, Cesario ^a   Li, Jianyi ^a   Sellke, Frank W ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

31

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTIBODY; CASPASE 3; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOPLEGIA; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTALLOID; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART ARREST; HEART LEFT VENTRICLE PERFORMANCE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; IMMUNOBLOTTING; ISOLATED HEART; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RABBIT; REPERFUSION; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BLOOD; CARDIOPLEGIC SOLUTIONS; CARRIER PROTEINS; CASPASE 3; CASPASES; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HEART ARREST, INDUCED; PHOSPHORYLATION; POTASSIUM COMPOUNDS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RABBITS; VASODILATION; VENTRICULAR FUNCTION, LEFT;

EID: 1842480171     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.09.053     Document Type: Article

References (25)

1. Barner H.B. Blood cardioplegia a review and comparison with crystalloid cardioplegia. Ann Thorac Surg. 52:1991;1354-1367.
2. Sellke F.W., Shafique T., Schoen F.J., Weintraub R.M. Impaired endothelium-dependent coronary microvascular relaxation after cold potassium cardioplegia and reperfusion. J Thorac Cardiovasc Surg. 105:1993;52-58.
3. Sellke F.W., Shafique T., Johnson R.G., et al. Blood and albumin cardioplegia preserve endothelium-dependent microvascular responses. Ann Thorac Surg. 55:1993;977-985.
4. Wang S.Y., Stamler A., Tofukuji M., Deuson T.E., Sellke F.W. Effects of blood and crystalloid cardioplegia on adrenergic and myogenic vascular mechanisms. Ann Thorac Surg. 63:1997;41-49.
5. Schmitt J.P., Schrader J., Schunkert H., Birnbaum D.E., Aebert H. Role of apoptosis in myocardial stunning after open heart surgery. Ann Thorac Surg. 73:2002;1229-1235.
6. Valen G. The basic biology of apoptosis and its implications for cardiac function and viability. Ann Thorac Surg. 75:2003;S656-S660.
7. Majno G., Joris I. Apoptosis, oncosis, and necrosis. an overview of cell death. Am J Pathol. 146:1995;3-15.
8. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;11621-11628.
9. Saraste A., Pulkki K., Kallajoki M., et al. Apoptosis in human myocardial infarction. Circulation. 95:1997;320-323.
10. Scarabelli T., Stephanou A., Rayment N., et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation. 104:2001;253-256.
11. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members, and the mitochondria in apoptosis. Genes Development. 13:1999;1899-1911.
12. Steenbergen C, Afsharl CA, Petranka JG, et al. Alterations in apoptosis signaling in human idiopathic cardiomyopathic hearts in failure. Am J Physiol 2002;284:H268-76
13. Bianchi C., Araujo E.G., Sato K., Sellke F.W. Biochemical and structural evidence for pig myocardium adherens junction disruption by cardiopulmanory bypass. Circulation. 104:2001;I319-324.
14. Follette D.M., Fey K., Buckberg G.D., et al. Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity. J Thorac Cardiovasc Surg. 82:1981;221-238.
15. Brown W.M., Jay J.L., Gott J.P., et al. Warm blood cardioplegia superior protection after acute myocardial ischemia. Ann Thorac Surg. 55:1993;32-42.
16. Yeh C.H., Wang Y.C., Wu Y.C., Chu J.J., Lin P.J. Continuous tepid blood cardioplegia can preserve coronary endothelium and ameliorate the occurrence of cardiomyocyte apoptosis. Chest. 123:2003;1647-1654.
17. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
18. Chandrashekhar Y., Narula J. Death hath a thousand doors to let out life...*. Circ Res. 92:2003;710-714.
19. Baines C.P., Zhang J., Wang G.W., et al. Mitochondrial PKCε and MAPK form signaling modules in the murine heart. Circ Res. 90:2002;390-397.
20. Zhao Z.Q., Nakamura M., Wang N.P., et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res. 45:2000;6651-6660.
21. Zhao Z.Q., Budde J.M., Morris C., et al. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J Mol Cell Cardiol. 33:2001;57-68.
22. Chen Z., Chua C.C., Ho Y.S., Hamdy R.C., Chua B.H. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol. 280:2001;H2313-2320.
23. Maulik N., Goswami S., Galang N., Das D.K. Differential regulation of Bcl-2, AP-1, and NFkB on cardiomyocyte apoptosis during myocardial ischemic stress adaption. FEBS Lett. 443:1999;331-336.
24. Ruetten H., Badorff C., Ihling C., Zeiher A.M., Dimmeler S. Inhibition of caspase 3 improves contractile recovery of stunned myocardium, independent of apoptotsis inhibiting effects. J Am Coll Cardiol. 38:2001;2063-2070.
25. Condorelli G., Roncarati R., Ross J. Jr, et al. Heart-targeted overexpression of caspase 3 in mice increases infarct size, and depresses cardiac function. Proc Natl Acad Sci USA. 98:2001;9977-9982.